
Christopher C. Caillouet
Examiner (ID: 8951, Phone: (571)270-3968 , Office: P/1745 )
| Most Active Art Unit | 1745 |
| Art Unit(s) | 1791, 1745 |
| Total Applications | 862 |
| Issued Applications | 546 |
| Pending Applications | 67 |
| Abandoned Applications | 259 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5224917
[patent_doc_number] => 20070254183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-01
[patent_title] => 'Electroluminescent materials and deivces'
[patent_app_type] => utility
[patent_app_number] => 11/660626
[patent_app_country] => US
[patent_app_date] => 2005-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 4719
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20070254183.pdf
[firstpage_image] =>[orig_patent_app_number] => 11660626
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/660626 | Electroluminescent materials and deivces | Aug 25, 2005 | Abandoned |
Array
(
[id] => 5895462
[patent_doc_number] => 20060004001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-05
[patent_title] => 'Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors'
[patent_app_type] => utility
[patent_app_number] => 11/211829
[patent_app_country] => US
[patent_app_date] => 2005-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19433
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20060004001.pdf
[firstpage_image] =>[orig_patent_app_number] => 11211829
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/211829 | Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors | Aug 24, 2005 | Abandoned |
Array
(
[id] => 285555
[patent_doc_number] => 07550482
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-06-23
[patent_title] => 'Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors'
[patent_app_type] => utility
[patent_app_number] => 11/210569
[patent_app_country] => US
[patent_app_date] => 2005-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16006
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/550/07550482.pdf
[firstpage_image] =>[orig_patent_app_number] => 11210569
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/210569 | Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors | Aug 23, 2005 | Issued |
| 11/206158 | 2,6-Quinolinyl derivatives, processes for preparing them and their uses | Aug 17, 2005 | Abandoned |
Array
(
[id] => 285671
[patent_doc_number] => 07550598
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-06-23
[patent_title] => 'Kinase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/208437
[patent_app_country] => US
[patent_app_date] => 2005-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38401
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/550/07550598.pdf
[firstpage_image] =>[orig_patent_app_number] => 11208437
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/208437 | Kinase inhibitors | Aug 17, 2005 | Issued |
Array
(
[id] => 5801536
[patent_doc_number] => 20060035931
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-16
[patent_title] => 'Crystalline form of a biphenyl compound'
[patent_app_type] => utility
[patent_app_number] => 11/204065
[patent_app_country] => US
[patent_app_date] => 2005-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 22061
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20060035931.pdf
[firstpage_image] =>[orig_patent_app_number] => 11204065
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/204065 | Crystalline form of a biphenyl compound | Aug 14, 2005 | Issued |
Array
(
[id] => 311228
[patent_doc_number] => 07528253
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-05-05
[patent_title] => 'Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity'
[patent_app_type] => utility
[patent_app_number] => 11/204066
[patent_app_country] => US
[patent_app_date] => 2005-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35599
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/528/07528253.pdf
[firstpage_image] =>[orig_patent_app_number] => 11204066
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/204066 | Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity | Aug 14, 2005 | Issued |
Array
(
[id] => 4670477
[patent_doc_number] => 20080045537
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-21
[patent_title] => 'Chemical Compounds'
[patent_app_type] => utility
[patent_app_number] => 11/573729
[patent_app_country] => US
[patent_app_date] => 2005-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 73036
[patent_no_of_claims] => 69
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20080045537.pdf
[firstpage_image] =>[orig_patent_app_number] => 11573729
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/573729 | Chemical Compounds | Aug 11, 2005 | Abandoned |
Array
(
[id] => 5801535
[patent_doc_number] => 20060035930
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-16
[patent_title] => '4-(2,4-dichloro-5-methoxyphenyl)amino-6-methoxy-7-{[5-substituted -amino)methyl]-3-furyl}-3-quinolinecarbonitriles as kinase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/201705
[patent_app_country] => US
[patent_app_date] => 2005-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11282
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20060035930.pdf
[firstpage_image] =>[orig_patent_app_number] => 11201705
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/201705 | 4-(2,4-dichloro-5-methoxyphenyl)amino-6-methoxy-7-{[5-substituted-amino)methyl]-3-furyl}-3-quinolinecarbonitriles as kinase inhibitors | Aug 10, 2005 | Issued |
Array
(
[id] => 4461664
[patent_doc_number] => 07880006
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-02-01
[patent_title] => 'Quinoline derivatives and insecticide comprising thereof as active ingredient'
[patent_app_type] => utility
[patent_app_number] => 11/632420
[patent_app_country] => US
[patent_app_date] => 2005-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49931
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/880/07880006.pdf
[firstpage_image] =>[orig_patent_app_number] => 11632420
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/632420 | Quinoline derivatives and insecticide comprising thereof as active ingredient | Aug 2, 2005 | Issued |
Array
(
[id] => 4760048
[patent_doc_number] => 20080312274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-18
[patent_title] => 'Quinoline Derivatives as Neurokinin Receptor Antagonists'
[patent_app_type] => utility
[patent_app_number] => 11/659401
[patent_app_country] => US
[patent_app_date] => 2005-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6258
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20080312274.pdf
[firstpage_image] =>[orig_patent_app_number] => 11659401
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/659401 | Quinoline Derivatives as Neurokinin Receptor Antagonists | Jul 27, 2005 | Abandoned |
Array
(
[id] => 4916284
[patent_doc_number] => 20080096885
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-24
[patent_title] => 'Quinoline Derivatives as Neurokinin Receptor Antagonists'
[patent_app_type] => utility
[patent_app_number] => 11/659399
[patent_app_country] => US
[patent_app_date] => 2005-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13012
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20080096885.pdf
[firstpage_image] =>[orig_patent_app_number] => 11659399
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/659399 | Quinoline Derivatives as Neurokinin Receptor Antagonists | Jul 27, 2005 | Abandoned |
Array
(
[id] => 5829204
[patent_doc_number] => 20060063803
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-23
[patent_title] => '4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds'
[patent_app_type] => utility
[patent_app_number] => 11/187854
[patent_app_country] => US
[patent_app_date] => 2005-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 44946
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20060063803.pdf
[firstpage_image] =>[orig_patent_app_number] => 11187854
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/187854 | 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds | Jul 24, 2005 | Abandoned |
Array
(
[id] => 5297192
[patent_doc_number] => 20090012118
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-08
[patent_title] => 'Kynurenic Acid Amide Derivatives as Nr2b Receptor Antagoni'
[patent_app_type] => utility
[patent_app_number] => 11/658690
[patent_app_country] => US
[patent_app_date] => 2005-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6226
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0012/20090012118.pdf
[firstpage_image] =>[orig_patent_app_number] => 11658690
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/658690 | Kynurenic Acid Amide Derivatives as Nr2b Receptor Antagoni | Jul 20, 2005 | Abandoned |
Array
(
[id] => 6931846
[patent_doc_number] => 20050282881
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-22
[patent_title] => 'Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/185349
[patent_app_country] => US
[patent_app_date] => 2005-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45264
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0282/20050282881.pdf
[firstpage_image] =>[orig_patent_app_number] => 11185349
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/185349 | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof | Jul 19, 2005 | Issued |
Array
(
[id] => 5608415
[patent_doc_number] => 20060269931
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-30
[patent_title] => 'Purine based fluorescent dyes'
[patent_app_type] => utility
[patent_app_number] => 11/177923
[patent_app_country] => US
[patent_app_date] => 2005-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4845
[patent_no_of_claims] => 89
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20060269931.pdf
[firstpage_image] =>[orig_patent_app_number] => 11177923
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/177923 | Purine based fluorescent dyes | Jul 6, 2005 | Issued |
Array
(
[id] => 318850
[patent_doc_number] => 07521560
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-04-21
[patent_title] => '2-substituted quinoline compounds and their uses'
[patent_app_type] => utility
[patent_app_number] => 11/171580
[patent_app_country] => US
[patent_app_date] => 2005-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 18790
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/521/07521560.pdf
[firstpage_image] =>[orig_patent_app_number] => 11171580
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/171580 | 2-substituted quinoline compounds and their uses | Jun 28, 2005 | Issued |
Array
(
[id] => 7593060
[patent_doc_number] => 07652141
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-01-26
[patent_title] => 'Pyridone derivatives having a binding activity to the cannabinoid type 2 receptor'
[patent_app_type] => utility
[patent_app_number] => 11/168640
[patent_app_country] => US
[patent_app_date] => 2005-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 96925
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/652/07652141.pdf
[firstpage_image] =>[orig_patent_app_number] => 11168640
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/168640 | Pyridone derivatives having a binding activity to the cannabinoid type 2 receptor | Jun 28, 2005 | Issued |
Array
(
[id] => 4688804
[patent_doc_number] => 20080032985
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-07
[patent_title] => '4-Substituted Quinoline Derivatives, Method and Intermediates for Their Preparation and Pharmaceutical Compositions Containing Them'
[patent_app_type] => utility
[patent_app_number] => 11/571407
[patent_app_country] => US
[patent_app_date] => 2005-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16145
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20080032985.pdf
[firstpage_image] =>[orig_patent_app_number] => 11571407
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/571407 | 4-Substituted Quinoline Derivatives, Method and Intermediates for Their Preparation and Pharmaceutical Compositions Containing Them | Jun 23, 2005 | Abandoned |
Array
(
[id] => 348987
[patent_doc_number] => 07495103
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-02-24
[patent_title] => 'Modulators of ATP-binding cassette transporters'
[patent_app_type] => utility
[patent_app_number] => 11/165818
[patent_app_country] => US
[patent_app_date] => 2005-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 88500
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/495/07495103.pdf
[firstpage_image] =>[orig_patent_app_number] => 11165818
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/165818 | Modulators of ATP-binding cassette transporters | Jun 23, 2005 | Issued |